172 studies found for:    Nanoparticles
Show Display Options
Rank Status Study
1 Recruiting Clinical Study on the Harvesting Lymph Nodes With Carbon Nanoparticles for Advanced Gastric Cancer
Condition: Advanced Gastric Cancer
Interventions: Drug: Carbon Nanoparticles;   Procedure: Gastrectomy with D2 dissection
2 Active, not recruiting Fluor Varnish With Silver Nanoparticles for Dental Remineralization in Patients With Trisomy 21
Condition: Down Syndrome
Interventions: Drug: Fluor varnish;   Drug: Fluor varnish with nanoparticles
3 Unknown  Pilot Study - Putative Penetration of Nanoparticles in Sunscreen in Intact or Sunburned Skin
Conditions: Healthy Skin;   Sunburned Skin;   Titanium Dioxide;   Nanoparticles;   Penetrate Skin
Intervention:
4 Not yet recruiting C-VISA BikDD: Liposome in Advanced Pancreatic Cancer
Condition: Pancreatic Cancer
Intervention: Genetic: BikDD Nanoparticle
5 Unknown  Antibacterial Properties of Silicon Incorporated With Quaternary Ammonium Polyethylenimine Nanoparticles
Condition: Carcinoma of Head and Neck
Intervention: Device: polyethylenimine (PEI) nanoparticles.
6 Active, not recruiting Capsaicin Nanoparticle in Patient With Painful Diabetic Neuropathy
Condition: Painful Diabetic Neuropathy
Interventions: Drug: 0.75% capsaicin nanoparticle cream;   Drug: Placebo
7 Recruiting Magnetic Nanoparticle Thermoablation-Retention and Maintenance in the Prostate:A Phase 0 Study in Men
Condition: Prostate Cancer
Intervention: Other: Magnetic Nanoparticle Injection
8 Completed
Has Results
Plasmonic Nanophotothermic Therapy of Atherosclerosis
Conditions: Stable Angina;   Heart Failure;   Atherosclerosis;   Multivessel Coronary Artery Disease
Interventions: Procedure: Transplantation of nanoparticles;   Procedure: Transplantation of iron-bearing nanoparticles;   Device: Put in stenting
9 Recruiting Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Older Patients With Metastatic Breast Cancer
Conditions: Male Breast Cancer;   Recurrent Breast Cancer;   Stage IV Breast Cancer
Interventions: Drug: paclitaxel albumin-stabilized nanoparticle formulation;   Other: questionnaire administration
10 Completed Comparison of Central Venous Catheters With Silver Nanoparticles Versus Conventional Catheters
Condition: Central Venous Catheter Related Infections
Interventions: Procedure: CVC impregnated with silver nanoparticles (AgTive®);   Procedure: CVC cannulation
11 Not yet recruiting Selinexor, Gemcitabine Hydrochloride, and Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients With Metastatic Pancreatic Cancer
Conditions: Acinar Cell Adenocarcinoma of the Pancreas;   Duct Cell Adenocarcinoma of the Pancreas;   Stage IV Pancreatic Cancer
Interventions: Drug: gemcitabine hydrochloride;   Drug: paclitaxel albumin-stabilized nanoparticle formulation;   Drug: selinexor;   Other: pharmacological study;   Other: laboratory biomarker analysis
12 Recruiting Paclitaxel Albumin-Stabilized Nanoparticle Formulation and Carboplatin Followed By Chemoradiation in Treating Patients With Recurrent Head and Neck Cancer
Conditions: Recurrent Salivary Gland Cancer;   Recurrent Squamous Cell Carcinoma of the Hypopharynx;   Recurrent Squamous Cell Carcinoma of the Larynx;   Recurrent Squamous Cell Carcinoma of the Lip and Oral Cavity;   Recurrent Squamous Cell Carcinoma of the Nasopharynx;   Recurrent Squamous Cell Carcinoma of the Oropharynx;   Recurrent Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity;   Recurrent Verrucous Carcinoma of the Larynx;   Recurrent Verrucous Carcinoma of the Oral Cavity;   Salivary Gland Squamous Cell Carcinoma;   Tongue Cancer
Interventions: Drug: carboplatin;   Drug: paclitaxel albumin-stabilized nanoparticle formulation;   Drug: fluorouracil;   Drug: hydroxyurea;   Procedure: therapeutic conventional surgery;   Radiation: radiation therapy;   Radiation: hyperfractionated radiation therapy;   Other: laboratory biomarker analysis
13 Completed
Has Results
Use of Nanoparticle Paclitaxel (ABI-007) for the Prevention of In-Stent Restenosis
Condition: Coronary Restenosis
Intervention: Drug: Nanoparticle Paclitaxel
14 Recruiting Intraperitoneal Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients With Advanced Cancer of the Peritoneal Cavity
Conditions: Ovarian Cancer;   Peritoneal Cavity Cancer;   Unspecified Adult Solid Tumor, Protocol Specific
Interventions: Drug: paclitaxel albumin-stabilized nanoparticle formulation;   Other: liquid chromatography;   Other: mass spectrometry;   Other: pharmacological study;   Other: laboratory biomarker analysis
15 Completed Clinical Study of Antibacterial Nanoparticles Incorporated in Composite Restorations
Condition: Oral Health
Intervention: Device: alkylated polyethylenimine nanoparticles antibacterial evaluation
16 Not yet recruiting Dovitinib Lactate, Gemcitabine Hydrochloride, and Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients With Advanced Solid Tumors or Pancreatic Cancer
Conditions: Duct Cell Adenocarcinoma of the Pancreas;   Recurrent Pancreatic Cancer;   Stage III Pancreatic Cancer;   Stage IV Pancreatic Cancer;   Unspecified Adult Solid Tumor, Protocol Specific
Interventions: Drug: dovitinib lactate;   Drug: gemcitabine hydrochloride;   Drug: paclitaxel albumin-stabilized nanoparticle formulation;   Other: pharmacological study;   Other: laboratory biomarker analysis
17 Unknown  The Differential Pattern of Deposition of Nano Particles in the Airways of Exposed Workers
Condition: Inadequate or Impaired Respiratory Function
Intervention:
18 Active, not recruiting Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Cisplatin, and Cetuximab Given Together With Radiation Therapy in Treating Patients With Locally Advanced Stage III or Stage IV Head and Neck Cancer
Condition: Head and Neck Cancer
Interventions: Biological: cetuximab;   Drug: cisplatin;   Drug: paclitaxel albumin-stabilized nanoparticle formulation;   Radiation: 3-dimensional conformal radiation therapy;   Radiation: intensity-modulated radiation therapy
19 Recruiting Paclitaxel Albumin-Stabilized Nanoparticle Formulation and Bevacizumab in Treating Patients With Stage IV Melanoma That Cannot be Removed by Surgery
Condition: Advanced Melanoma
Intervention: Drug: paclitaxel albumin-stabilized nanoparticle formulation
20 Recruiting Paclitaxel Albumin-Stabilized Nanoparticle Formulation and Gemcitabine Hydrochloride With or Without WEE1 Inhibitor MK-1775 in Treating Patients With Previously Untreated Pancreatic Cancer That Is Metastatic or Cannot Be Removed by Surgery
Conditions: Acinar Cell Adenocarcinoma of the Pancreas;   Duct Cell Adenocarcinoma of the Pancreas;   Stage III Pancreatic Cancer;   Stage IV Pancreatic Cancer
Interventions: Drug: paclitaxel albumin-stabilized nanoparticle formulation;   Drug: gemcitabine hydrochloride;   Drug: WEE1 inhibitor MK-1775;   Other: placebo;   Other: pharmacological study;   Other: laboratory biomarker analysis

Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results
Indicates status has not been verified in more than two years